4//SEC Filing
NEWLIN WILLIAM R 4
Accession 0001062993-23-015058
CIK 0001842939other
Filed
Jul 17, 8:00 PM ET
Accepted
Jul 18, 8:37 PM ET
Size
12.2 KB
Accession
0001062993-23-015058
Insider Transaction Report
Form 4
NEWLIN WILLIAM R
Director
Transactions
- Award
Stock Option (right to buy)
2023-07-14+108,167→ 108,167 totalExercise: $2.11Exp: 2031-09-23→ Common Stock (108,167 underlying) - Other
Common Stock Warrants
2023-07-14+35,304→ 35,304 total(indirect: By LLC)Exercise: $2.39Exp: 2032-09-30→ Common Stock (35,304 underlying) - Other
Common Stock Warrants
2023-07-14+482→ 482 total(indirect: By LLC)Exercise: $6.71Exp: 2024-09-30→ Common Stock (482 underlying)
Holdings
- 1,249,062(indirect: By LLC)
Common Stock
Footnotes (5)
- [F1]Mr. Newlin is Chairman and Founder of Newlin Investment 1 LLC. By virtue of this relationship, Mr. Newlin may be deemed to share beneficial ownership of the securities held of record by Newlin Investment 1 LLC. Mr. Newlin disclaims any such beneficial ownership except to the extent of his pecuniary interest.
- [F2]Options to purchase 108,167 shares of common stock of Legacy Carmell (as defined below) granted on September 23, 2021, which vest as follows: 25% vested on September 23, 2021 and the remaining 75% becomes vested in 36 equal monthly installments thereafter, subject to continued service through each vesting date.
- [F3]On July 14, 2023, Alpha Healthcare Acquisition Corp. III ("ALPA") consummated a business combination (the "Business Combination") by and among ALPA, Candy Merger Sub, Inc., a Delaware corporation ("Merger Sub") and Carmell Regen Med Corporation, a Delaware corporation ("Legacy Carmell"), ALPA changed its name to "Carmell Therapeutics Corporation" and Merger Sub merged with and into Legacy Carmell. As part of the Business Combination, each Legacy Carmell stock option was exchanged for a stock option to acquire 0.06154 shares of common stock of Carmell Therapeutics Corporation.
- [F4]These warrants are currently exercisable.
- [F5]As part of the Business Combination, (i) existing warrants to purchase common stock of Legacy Carmell were exchanged for 0.06154 warrants to purchase shares of common stock of Carmell Therapeutics Corporation and (ii) existing Series C-1 warrants to purchase common stock of Legacy Carmell were exchanged for 0.06684 warrants to purchase shares of common stock of Carmell Therapeutics Corporation.
Issuer
ALPHA HEALTHCARE ACQUISITION CORP III
CIK 0001842939
Entity typeother
Related Parties
1- filerCIK 0001076972
Filing Metadata
- Form type
- 4
- Filed
- Jul 17, 8:00 PM ET
- Accepted
- Jul 18, 8:37 PM ET
- Size
- 12.2 KB